Sio Gene Therapies Inc (SIOX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SIOX.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 5 | $12.5 | $7 | $8.5 | $2.49 | 241.37% |
The Trend in the Analyst Price Target
SIOX's average price target has moved down $0.38 over the prior 155 days.
Over the past 155 days, SIOX's average upside potential has been 233.83%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-13 | 5 | 12.5 | 7 | 8.50 | 2.49 | 241.37% |
| 2021-06-05 | 5 | 12.5 | 7 | 8.70 | 2.18 | 299.08% |
| 2021-05-22 | 5 | 12.5 | 7 | 8.70 | 2.19 | 297.26% |
| 2021-05-15 | 5 | 12.5 | 7 | 8.70 | 2.14 | 306.54% |
| 2021-05-08 | 5 | 12.5 | 7 | 8.70 | 2.67 | 225.84% |
| 2021-04-25 | 4 | 12.5 | 7 | 8.88 | 2.53 | 250.99% |
| 2021-04-17 | 4 | 12.5 | 7 | 8.88 | 2.45 | 262.45% |
| 2021-04-10 | 4 | 12.5 | 7 | 8.88 | 2.67 | 232.58% |
| 2021-04-03 | 4 | 12.5 | 7 | 8.88 | 2.85 | 211.58% |
| 2021-03-20 | 4 | 12.5 | 7 | 8.88 | 2.70 | 228.89% |
| 2021-03-13 | 4 | 12.5 | 7 | 8.88 | 2.82 | 214.89% |
| 2021-03-06 | 4 | 12.5 | 7 | 8.88 | 2.51 | 253.78% |
| 2021-02-27 | 4 | 12.5 | 7 | 8.88 | 2.64 | 236.36% |
| 2021-02-20 | 4 | 12.5 | 7 | 8.88 | 3.15 | 181.9% |
| 2021-02-13 | 4 | 12.5 | 7 | 8.88 | 3.31 | 168.28% |
| 2021-02-06 | 4 | 12.5 | 7 | 8.88 | 3.01 | 195.02% |
| 2021-01-30 | 4 | 12.5 | 7 | 8.88 | 2.53 | 250.99% |
| 2021-01-23 | 4 | 12.5 | 7 | 8.88 | 2.80 | 217.14% |
| 2021-01-16 | 4 | 12.5 | 7 | 8.88 | 2.86 | 210.49% |
| 2021-01-09 | 4 | 12.5 | 7 | 8.88 | 3.05 | 191.15% |
SIOX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 2 | 2 | 0 | 0 | 0 | 4 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Sio Gene Therapies Inc's upside potential (average analyst target price relative to current price) is higher than 95.06% of all US stocks.
- SIOX has a higher average analyst price target than 8.4% of stocks in the mid market cap category.
- SIOX has a lower variance in analysts' estimates than 15.01% of all US stocks.
- The number of analysts covering the stock of SIOX is higher than 30.41% of stocks in the mid market cap category.
Stocks similar to Sio Gene Therapies Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are LBPH, ELDN and ONCY.
What is the outlook for SIOX? Use POWR Ratings for clearer insight into price direction.